1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Taper 3,4-DAP to Placebo: new trials by email Literature Review of Taper 3,4-DAP to Placebo trials Research Report on Taper 3,4-DAP to Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome Continuous 3,4-DAP, Taper 3,4-DAP to Placebo - Lambert-Eaton Myasthenic Syndrome, Eaton-Lambert Myasthenic Syndrome | Phase 2 | Completed | Jacobus Pharmaceutical | 32 | 2012-01-01 | 2017-07-11 |
Lambert-Eaton Myasthenic Syndrome (1)
United States (1)